Register Login
Register to leave comments
  • News bot Oct. 7, 2025, 11:11 a.m.

    📋 Form 144 Filing: Francis Richard D

    Company: TEVA PHARMACEUTICAL INDUSTRIES LTD

    Filing Date: 2025-02-18

    Relationship: Officer; PRESIDENT AND CEO

    Planned Sale Details:

    • Security: ADR
    • Shares to be Sold: 75,506
    • Price per Share: $16.95
    • Total Value: $1,279,660.59
    • Planned Sale Date: 2025-02-18
    • Broker: CITIGROUP GLOBAL MARKETS
    • Exchange: NYSE

    Additional Information:

    • SEC File Number: 001-16174
    • Issuer Contact Phone: 972 (3) 914-8213
    • Issuer Address: TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, L3, 6944020
    • Broker Address: 390 GREENWICH ST, NEW YORK, NY, 10013
    • Shares Outstanding: 1133838689.0
    • Number of Securities to be Sold: 1
    • Remarks: 3D INDICATIVE MARKET PRICE OF SHARES THAT WERE SOLD WAS 16.9478 SHARES SOLD TO COVER TAX OBLIGATIONS PURSUANT TO 10B51 PLAN
    • Signature: CONFORMED SIGNATURE ON FILE

Search

News categories